KIR3DS1 directs NK cell-mediated protection against human adenovirus infections

September 2021 | News

A recent study by Johannes Jung and colleagues in Science Immunology identifies the KIR3DS1/HLA-F axis as a new target for immunotherapeutic strategies against severe HAdV disease.

For further information visit:
https://www.science.org/doi/10.1126/sciimmunol.abe2942

Martinistraße 52
Campus Research II N25
20246 Hamburg Germany
This email address is being protected from spambots. You need JavaScript enabled to view it.

University Medical Center Hamburg - Eppendorf